Medicare Bill May Cause Insurers To Look At OTCs With Cost Cuts In Mind
This article was originally published in The Tan Sheet
Executive Summary
WellPoint Health Networks says that Congress' pending Medicare legislation could promote an aggressive move by consumers to OTC drugs
You may also be interested in...
Medicare bill
Senate clears the conference report on the "Medicare Prescription Drug & Modernization Act of 2003" (HR 1) in a 54-44 vote Nov. 25, following House passage Nov. 22. Some Democrats, including Senate HELP Committee Chairman Edward Kennedy (D-Mass.) continue to oppose the bill. Kennedy maintains the bill will have to be revisited in Congress during the 2004 session. Insurance and OTC industry insiders have indicated the bill's drug provisions could provide a boost to OTC use (1"The Tan Sheet" Nov. 24 2003, p. 6)...
Medicare bill
Senate clears the conference report on the "Medicare Prescription Drug & Modernization Act of 2003" (HR 1) in a 54-44 vote Nov. 25, following House passage Nov. 22. Some Democrats, including Senate HELP Committee Chairman Edward Kennedy (D-Mass.) continue to oppose the bill. Kennedy maintains the bill will have to be revisited in Congress during the 2004 session. Insurance and OTC industry insiders have indicated the bill's drug provisions could provide a boost to OTC use (1"The Tan Sheet" Nov. 24 2003, p. 6)...
Medicare bill
Senate clears the conference report on the "Medicare Prescription Drug & Modernization Act of 2003" (HR 1) in a 54-44 vote Nov. 25, following House passage Nov. 22. Some Democrats, including Senate HELP Committee Chairman Edward Kennedy (D-Mass.) continue to oppose the bill. Kennedy maintains the bill will have to be revisited in Congress during the 2004 session. Insurance and OTC industry insiders have indicated the bill's drug provisions could provide a boost to OTC use (1"The Tan Sheet" Nov. 24 2003, p. 6)...